title: The ER-positive/PgR-negative breast cancer phenotype is not associated with mutations within the DNA binding domain.
abstract: We have used in vitro DNA binding assays as a measure of estrogen receptor (ER) function in human breast tumors. We found that the majority of ER+ (25 ER+/progesterone receptor [PgR]+, and 25 ER+/PgR-) tumors we examined were capable of binding consensus estrogen response element (ERE) oligonucleotides in this assay system. We found significant proteolytic activity in many of the tumors such that protease inhibitors were found to be essential during the preparation of tumor extracts. We next applied direct sequence analysis of the ER DNA binding domain of several of these tumors, and determined that the ER+/PgR- breast tumors did not contain mutations within the DNA binding domain which might explain their apparent discordant receptor phenotype. We did identify an alternatively spliced ER variant missing exon 3 of the DNA binding domain. This variant was unable to function as a transcriptional inducer of an estrogen-responsive reporter in a yeast assay system. Furthermore, the exon 3 ER deletion variant was expressed at equivalent levels in all of the ER+ breast tumors, so that it does not appear to be involved in the evolution of the ER+/PgR- breast cancer phenotype.
authors.affiliation: University of Texas Health Science Center, Department of Medicine/Oncology, San Antonio 78284-7884.
authors.forename: S A
authors.initials: SA
authors.lastname: Fuqua
authors.forename: D C
authors.initials: DC
authors.lastname: Allred
authors.forename: R M
authors.initials: RM
authors.lastname: Elledge
authors.forename: S L
authors.initials: SL
authors.lastname: Krieg
authors.forename: M G
authors.initials: MG
authors.lastname: Benedix
authors.forename: Z
authors.initials: Z
authors.lastname: Nawaz
authors.forename: B W
authors.initials: BW
authors.lastname: O'Malley
authors.forename: G L
authors.initials: GL
authors.lastname: Greene
authors.forename: W L
authors.initials: WL
authors.lastname: McGuire
mesh_terms: D001483:Base Sequence; D001943:Breast Neoplasms / Q000737:chemistry / Q000235:genetics*; D004273:DNA, Neoplasm / Q000235:genetics; D004268:DNA-Binding Proteins / Q000032:analysis / Q000235:genetics*; D005091:Exons / Q000235:genetics*; D005260:Female; D006801:Humans; D008969:Molecular Sequence Data; D009154:Mutation; D010641:Phenotype; D011960:Receptors, Estrogen / Q000032:analysis / Q000235:genetics*; D011980:Receptors, Progesterone / Q000032:analysis*; D017422:Sequence Analysis, DNA; D014158:Transcription, Genetic
chemical_list: D004273:DNA, Neoplasm; D004268:DNA-Binding Proteins; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone